Immediate Impact
4 from Science/Nature 64 standout
Citing Papers
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Works of Beth Nordstrom being referenced
Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes
2017
Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta‐analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Beth Nordstrom | 270 | 333 | 281 | 448 | 372 | 80 | 2.7k | |
| S. Pampallona | 465 | 768 | 233 | 294 | 373 | 81 | 3.2k | |
| Jason Oke | 421 | 332 | 495 | 108 | 408 | 92 | 4.0k | |
| Denise Globe | 375 | 171 | 95 | 272 | 268 | 104 | 3.5k | |
| Jong Heon Park | 273 | 347 | 590 | 107 | 406 | 83 | 3.0k | |
| Pamela Royle | 252 | 190 | 207 | 238 | 240 | 69 | 4.2k | |
| Benoît Arnould | 155 | 102 | 75 | 259 | 195 | 106 | 1.9k | |
| Bruce Crawford | 283 | 200 | 124 | 78 | 160 | 79 | 2.7k | |
| Eric B. Schneider | 365 | 280 | 348 | 211 | 404 | 100 | 3.3k | |
| Sachiko Ohde | 300 | 318 | 89 | 99 | 392 | 124 | 1.9k | |
| Lindsey R. Sangaralingham | 373 | 157 | 1974 | 151 | 153 | 132 | 3.7k |
All Works
Login with ORCID to disown or claim papers
Loading papers...